Cargando…

Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series

With the increasing availability of high-performance medical imaging for the management of patients with neuroendocrine tumors (NETs), a progressive growth of asymptomatic and incidentally detected cardiac metastases (CMs) has been observed in the recent years. In clinical practice, CMs of NENs are...

Descripción completa

Detalles Bibliográficos
Autores principales: El Ghannudi, Soraya, Ouvrard, Eric, Mikail, Nidaa, Leroy Freschini, Benjamin, Schindler, Thomas H., Imperiale, Alessio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139778/
https://www.ncbi.nlm.nih.gov/pubmed/35626337
http://dx.doi.org/10.3390/diagnostics12051182
_version_ 1784714938104676352
author El Ghannudi, Soraya
Ouvrard, Eric
Mikail, Nidaa
Leroy Freschini, Benjamin
Schindler, Thomas H.
Imperiale, Alessio
author_facet El Ghannudi, Soraya
Ouvrard, Eric
Mikail, Nidaa
Leroy Freschini, Benjamin
Schindler, Thomas H.
Imperiale, Alessio
author_sort El Ghannudi, Soraya
collection PubMed
description With the increasing availability of high-performance medical imaging for the management of patients with neuroendocrine tumors (NETs), a progressive growth of asymptomatic and incidentally detected cardiac metastases (CMs) has been observed in the recent years. In clinical practice, CMs of NENs are often incidentally detected by whole-body (68)Ga-labeled somatostatin analogs or (18)F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography, and afterwards accurately characterized by cardiac magnetic resonance (CMR) and/or gated cardiac computed tomography when CMR is contraindicated or not available. The interpreting physician should familiarize with the main imaging features of CM, a finding that may be encountered in NETs patients more than previously thought. Herein, we present a case series of four patients with CMs from small-intestine NETs highlighting strengths and weaknesses of a multimodality imaging approach in clinical practice.
format Online
Article
Text
id pubmed-9139778
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91397782022-05-28 Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series El Ghannudi, Soraya Ouvrard, Eric Mikail, Nidaa Leroy Freschini, Benjamin Schindler, Thomas H. Imperiale, Alessio Diagnostics (Basel) Brief Report With the increasing availability of high-performance medical imaging for the management of patients with neuroendocrine tumors (NETs), a progressive growth of asymptomatic and incidentally detected cardiac metastases (CMs) has been observed in the recent years. In clinical practice, CMs of NENs are often incidentally detected by whole-body (68)Ga-labeled somatostatin analogs or (18)F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography, and afterwards accurately characterized by cardiac magnetic resonance (CMR) and/or gated cardiac computed tomography when CMR is contraindicated or not available. The interpreting physician should familiarize with the main imaging features of CM, a finding that may be encountered in NETs patients more than previously thought. Herein, we present a case series of four patients with CMs from small-intestine NETs highlighting strengths and weaknesses of a multimodality imaging approach in clinical practice. MDPI 2022-05-09 /pmc/articles/PMC9139778/ /pubmed/35626337 http://dx.doi.org/10.3390/diagnostics12051182 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
El Ghannudi, Soraya
Ouvrard, Eric
Mikail, Nidaa
Leroy Freschini, Benjamin
Schindler, Thomas H.
Imperiale, Alessio
Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series
title Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series
title_full Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series
title_fullStr Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series
title_full_unstemmed Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series
title_short Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series
title_sort cutting-edge imaging of cardiac metastases from neuroendocrine tumors: lesson from a case series
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139778/
https://www.ncbi.nlm.nih.gov/pubmed/35626337
http://dx.doi.org/10.3390/diagnostics12051182
work_keys_str_mv AT elghannudisoraya cuttingedgeimagingofcardiacmetastasesfromneuroendocrinetumorslessonfromacaseseries
AT ouvrarderic cuttingedgeimagingofcardiacmetastasesfromneuroendocrinetumorslessonfromacaseseries
AT mikailnidaa cuttingedgeimagingofcardiacmetastasesfromneuroendocrinetumorslessonfromacaseseries
AT leroyfreschinibenjamin cuttingedgeimagingofcardiacmetastasesfromneuroendocrinetumorslessonfromacaseseries
AT schindlerthomash cuttingedgeimagingofcardiacmetastasesfromneuroendocrinetumorslessonfromacaseseries
AT imperialealessio cuttingedgeimagingofcardiacmetastasesfromneuroendocrinetumorslessonfromacaseseries